rs1139538

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000462091.5(UMPS):​n.-28A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.584 in 1,612,770 control chromosomes in the GnomAD database, including 277,549 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 23578 hom., cov: 32)
Exomes 𝑓: 0.59 ( 253971 hom. )

Consequence

UMPS
ENST00000462091.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: -1.35

Publications

21 publications found
Variant links:
Genes affected
UMPS (HGNC:12563): (uridine monophosphate synthetase) This gene encodes a uridine 5'-monophosphate synthase. The encoded protein is a bifunctional enzyme that catalyzes the final two steps of the de novo pyrimidine biosynthetic pathway. The first reaction is carried out by the N-terminal enzyme orotate phosphoribosyltransferase which converts orotic acid to orotidine-5'-monophosphate. The terminal reaction is carried out by the C-terminal enzyme OMP decarboxylase which converts orotidine-5'-monophosphate to uridine monophosphate. Defects in this gene are the cause of hereditary orotic aciduria. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
UMPS Gene-Disease associations (from GenCC):
  • orotic aciduria
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 3-124730444-A-G is Benign according to our data. Variant chr3-124730444-A-G is described in ClinVar as Benign. ClinVar VariationId is 100126.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.659 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UMPSNM_000373.4 linkc.-28A>G upstream_gene_variant ENST00000232607.7 NP_000364.1
UMPSNR_033434.2 linkn.-8A>G upstream_gene_variant
UMPSNR_033437.2 linkn.-8A>G upstream_gene_variant
UMPSXR_001740253.3 linkn.-8A>G upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UMPSENST00000232607.7 linkc.-28A>G upstream_gene_variant 1 NM_000373.4 ENSP00000232607.2

Frequencies

GnomAD3 genomes
AF:
0.549
AC:
83484
AN:
151940
Hom.:
23564
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.419
Gnomad AMI
AF:
0.478
Gnomad AMR
AF:
0.670
Gnomad ASJ
AF:
0.609
Gnomad EAS
AF:
0.659
Gnomad SAS
AF:
0.623
Gnomad FIN
AF:
0.521
Gnomad MID
AF:
0.598
Gnomad NFE
AF:
0.589
Gnomad OTH
AF:
0.589
GnomAD2 exomes
AF:
0.606
AC:
152139
AN:
251240
AF XY:
0.606
show subpopulations
Gnomad AFR exome
AF:
0.413
Gnomad AMR exome
AF:
0.739
Gnomad ASJ exome
AF:
0.610
Gnomad EAS exome
AF:
0.682
Gnomad FIN exome
AF:
0.530
Gnomad NFE exome
AF:
0.590
Gnomad OTH exome
AF:
0.614
GnomAD4 exome
AF:
0.588
AC:
858625
AN:
1460710
Hom.:
253971
Cov.:
51
AF XY:
0.589
AC XY:
427604
AN XY:
726566
show subpopulations
African (AFR)
AF:
0.410
AC:
13704
AN:
33446
American (AMR)
AF:
0.730
AC:
32630
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.608
AC:
15874
AN:
26120
East Asian (EAS)
AF:
0.633
AC:
25108
AN:
39666
South Asian (SAS)
AF:
0.612
AC:
52744
AN:
86222
European-Finnish (FIN)
AF:
0.528
AC:
28194
AN:
53352
Middle Eastern (MID)
AF:
0.602
AC:
3296
AN:
5474
European-Non Finnish (NFE)
AF:
0.586
AC:
651729
AN:
1111408
Other (OTH)
AF:
0.586
AC:
35346
AN:
60316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
18013
36026
54039
72052
90065
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17934
35868
53802
71736
89670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.549
AC:
83539
AN:
152060
Hom.:
23578
Cov.:
32
AF XY:
0.552
AC XY:
41034
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.420
AC:
17403
AN:
41484
American (AMR)
AF:
0.670
AC:
10249
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.609
AC:
2116
AN:
3472
East Asian (EAS)
AF:
0.658
AC:
3391
AN:
5152
South Asian (SAS)
AF:
0.621
AC:
2988
AN:
4810
European-Finnish (FIN)
AF:
0.521
AC:
5498
AN:
10558
Middle Eastern (MID)
AF:
0.592
AC:
174
AN:
294
European-Non Finnish (NFE)
AF:
0.589
AC:
40040
AN:
67972
Other (OTH)
AF:
0.589
AC:
1244
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1947
3893
5840
7786
9733
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
720
1440
2160
2880
3600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.583
Hom.:
18244
Bravo
AF:
0.556
Asia WGS
AF:
0.626
AC:
2179
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Diasio Lab, Mayo Clinic
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oroticaciduria Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.13
DANN
Benign
0.38
PhyloP100
-1.4
PromoterAI
0.10
Neutral
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1139538; hg19: chr3-124449291; COSMIC: COSV51739227; COSMIC: COSV51739227; API